semaglutide b12 compound weight loss with B12: Boost energy and enhance The FDA's Decision to Ban
Description
Poison Control reports getting an average of one to two calls a day about GLP-1 drugs, with 80% of the cases involving a mistake when administering the drug
Patient-level considerations Clinicians considering GLP-1 RAs for patients with suboptimally controlled hypertension should be mindful of existing antihypertensive therapy
doi: 10.1056/NEJMoa1008862
it means its actively being studied for exactly these reasons
It's that eating feels calmer and more manageable
